FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3085882014> ?p ?o ?g. }

• W3085882014 endingPage "343" @default.
• W3085882014 startingPage "335" @default.
• W3085882014 abstract "Lixisenatide, a glucagon‐like peptide‐1 (GLP‐1) receptor agonist, is used in the treatment of type 2 diabetes mellitus (T2DM). It increases insulin (INS) secretion and can decrease INS resistance, improving metabolic disorders in this disease. However, its effects on metabolic disturbances in cancer‐bearing, which also exhibit decreased INS secretion and INS resistance, changes that may contribute to weight loss (cachexia), have not yet been evaluated. The purpose of this study was to investigate the lixisenatide treatment effects on mild cachexia and related metabolic abnormalities in Walker‐256 tumour‐bearing rats. Lixisenatide (50 μg kg −1 , SC) was administered once daily, for 6 days, after inoculation of Walker‐256 tumour cells. Acute lixisenatide treatment did not improve hypoinsulinemia, INS secretion and INS resistance of tumour‐bearing rats. It also did not prevent the reduced glucose and increased triacylglycerol and lactate in the blood and nor the loss of retroperitoneal and epididymal fat of these animals. However, acute lixisenatide treatment accentuated the body mass loss of tumour‐bearing rats. Therefore, lixisenatide, unlike T2DM, does not improve hypoinsulinemia and INS resistance associated with cancer, evidencing that it does not have the same beneficial effects in these two diseases. In addition, lixisenatide aggravated weight loss of tumour‐bearing rats, suggesting that its use for treatment of T2DM patients with cancer should be avoided. Significance of the study Lixisenatide increases insulin secretion and appears to reduce insulin resistance in T2DM. However, lixisenatide treatment does not improve hypoinsulinemia and insulin resistance associated with cancer, as it does in T2DM, and aggravated weight loss, suggesting that its use for treatment of T2DM patients with cancer should be avoided." @default.
• W3085882014 created "2020-09-21" @default.
• W3085882014 creator A5018514871 @default.
• W3085882014 creator A5018611258 @default.
• W3085882014 creator A5034597666 @default.
• W3085882014 creator A5037861191 @default.
• W3085882014 creator A5055282423 @default.
• W3085882014 creator A5068890397 @default.
• W3085882014 creator A5081846149 @default.
• W3085882014 creator A5083641302 @default.
• W3085882014 creator A5088649222 @default.
• W3085882014 date "2020-09-10" @default.
• W3085882014 modified "2023-09-27" @default.
• W3085882014 title "Effects of lixisenatide treatment on mild cachexia and related metabolic abnormalities in Walker‐256 tumour‐bearing rats" @default.
• W3085882014 cites W1533461932 @default.
• W3085882014 cites W1893681319 @default.
• W3085882014 cites W1964863934 @default.
• W3085882014 cites W1978569902 @default.
• W3085882014 cites W1981337582 @default.
• W3085882014 cites W1983411407 @default.
• W3085882014 cites W1985743763 @default.
• W3085882014 cites W1990089345 @default.
• W3085882014 cites W1990251709 @default.
• W3085882014 cites W2002757015 @default.
• W3085882014 cites W2010763118 @default.
• W3085882014 cites W2012803888 @default.
• W3085882014 cites W2013193807 @default.
• W3085882014 cites W2015674248 @default.
• W3085882014 cites W2020950228 @default.
• W3085882014 cites W2024764697 @default.
• W3085882014 cites W2030605970 @default.
• W3085882014 cites W2031055048 @default.
• W3085882014 cites W2031673150 @default.
• W3085882014 cites W2035957915 @default.
• W3085882014 cites W2044488792 @default.
• W3085882014 cites W2049203431 @default.
• W3085882014 cites W2050350804 @default.
• W3085882014 cites W2077751509 @default.
• W3085882014 cites W2084257534 @default.
• W3085882014 cites W2087787276 @default.
• W3085882014 cites W2095774646 @default.
• W3085882014 cites W2095994700 @default.
• W3085882014 cites W2107251975 @default.
• W3085882014 cites W2107794104 @default.
• W3085882014 cites W2116286254 @default.
• W3085882014 cites W2118768129 @default.
• W3085882014 cites W2120128459 @default.
• W3085882014 cites W2161051960 @default.
• W3085882014 cites W2166487029 @default.
• W3085882014 cites W2171216343 @default.
• W3085882014 cites W2178128098 @default.
• W3085882014 cites W2245763891 @default.
• W3085882014 cites W2259134248 @default.
• W3085882014 cites W2279428213 @default.
• W3085882014 cites W2413070508 @default.
• W3085882014 cites W2566101653 @default.
• W3085882014 cites W2782410567 @default.
• W3085882014 cites W3023173633 @default.
• W3085882014 doi "https://doi.org/10.1002/cbf.3588" @default.
• W3085882014 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/32911572" @default.
• W3085882014 hasPublicationYear "2020" @default.
• W3085882014 type Work @default.
• W3085882014 sameAs 3085882014 @default.
• W3085882014 citedByCount "0" @default.
• W3085882014 crossrefType "journal-article" @default.
• W3085882014 hasAuthorship W3085882014A5018514871 @default.
• W3085882014 hasAuthorship W3085882014A5018611258 @default.
• W3085882014 hasAuthorship W3085882014A5034597666 @default.
• W3085882014 hasAuthorship W3085882014A5037861191 @default.
• W3085882014 hasAuthorship W3085882014A5055282423 @default.
• W3085882014 hasAuthorship W3085882014A5068890397 @default.
• W3085882014 hasAuthorship W3085882014A5081846149 @default.
• W3085882014 hasAuthorship W3085882014A5083641302 @default.
• W3085882014 hasAuthorship W3085882014A5088649222 @default.
• W3085882014 hasConcept C121608353 @default.
• W3085882014 hasConcept C126322002 @default.
• W3085882014 hasConcept C134018914 @default.
• W3085882014 hasConcept C2776442814 @default.
• W3085882014 hasConcept C2777180221 @default.
• W3085882014 hasConcept C2777391703 @default.
• W3085882014 hasConcept C2777704314 @default.
• W3085882014 hasConcept C2779306644 @default.
• W3085882014 hasConcept C2780533449 @default.
• W3085882014 hasConcept C2910068830 @default.
• W3085882014 hasConcept C555293320 @default.
• W3085882014 hasConcept C71924100 @default.
• W3085882014 hasConceptScore W3085882014C121608353 @default.
• W3085882014 hasConceptScore W3085882014C126322002 @default.
• W3085882014 hasConceptScore W3085882014C134018914 @default.
• W3085882014 hasConceptScore W3085882014C2776442814 @default.
• W3085882014 hasConceptScore W3085882014C2777180221 @default.
• W3085882014 hasConceptScore W3085882014C2777391703 @default.
• W3085882014 hasConceptScore W3085882014C2777704314 @default.
• W3085882014 hasConceptScore W3085882014C2779306644 @default.
• W3085882014 hasConceptScore W3085882014C2780533449 @default.
• W3085882014 hasConceptScore W3085882014C2910068830 @default.
• W3085882014 hasConceptScore W3085882014C555293320 @default.
• W3085882014 hasConceptScore W3085882014C71924100 @default.

• next